SAT1 relative levels were reduced with 50% in the DS-AD group, but not significantly different to the HC group in either the LOAD or EOAD groups (Figure 8E), suggesting a differential mechanism for PA dysregulation in DS cases compared to the general population. The gene discussed is SAT1; the disease is Alzheimer disease.